BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33106368)

  • 1. Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs.
    Marsh ES; Keddie S; Terris-Prestholt F; D'Sa S; Lunn MP
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):172-176. PubMed ID: 33106368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
    Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
    Misawa S
    Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
    Khouri J; Nakashima M; Wong S
    JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
    Kamezaki K; Nagafuji K
    Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy.
    Naddaf E; Dispenzieri A; Mandrekar J; Mauermann ML
    Muscle Nerve; 2015 Oct; 52(4):658-9. PubMed ID: 26179010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs' by Marsh
    Kuwabara S; Suichi T; Misawa S
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):118-119. PubMed ID: 33219039
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and electrophysiological profiles in early recognition of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome.
    Wang Q; Liu P; Ji LL; Wu S; Feng GD; Wang X; Dong JH
    Chin Med J (Engl); 2019 Jul; 132(14):1666-1672. PubMed ID: 31268911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POEMS syndrome with Guillan-Barre syndrome-like acute onset: a case report and review of neurological progression in 30 cases.
    Isose S; Misawa S; Kanai K; Shibuya K; Sekiguchi Y; Nasu S; Fujimaki Y; Noto Y; Nakaseko C; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):678-80. PubMed ID: 20562460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
    Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ
    Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POEMS neuropathy: optimising diagnosis and management.
    Keddie S; D'Sa S; Foldes D; Carr AS; Reilly MM; Lunn MPT
    Pract Neurol; 2018 Aug; 18(4):278-290. PubMed ID: 29511110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
    Guo X; Qin X; Zhang Y; Huang C; Yu G
    J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2019 Jul; 94(7):812-827. PubMed ID: 31012139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POEMS syndrome: clinical update.
    Brown R; Ginsberg L
    J Neurol; 2019 Jan; 266(1):268-277. PubMed ID: 30498913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [POEMS-syndrome].
    Arkhipov IE; Vergunova IY; Malkova NA; Korobko DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7. Vyp. 2):15-21. PubMed ID: 37560829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An atypical presentation of POEMS syndrome with IgG kappa type M protein and normal VEGF level: Case report and review of literature.
    Pulivarthi S; Gurram MK
    J Cancer Res Ther; 2018; 14(3):679-681. PubMed ID: 29893339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
    Misawa S; Sato Y; Katayama K; Nagashima K; Aoyagi R; Sekiguchi Y; Sobue G; Koike H; Yabe I; Sasaki H; Watanabe O; Takashima H; Nishizawa M; Kawachi I; Kusunoki S; Mitsui Y; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
    Lancet Neurol; 2016 Oct; 15(11):1129-37. PubMed ID: 27496680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POEMS syndrome.
    Keddie S; Lunn MP
    Curr Opin Neurol; 2018 Oct; 31(5):551-558. PubMed ID: 30138145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [POEMS syndrome diagnosed by detection of M-protein on immunofixation and increased level of vascular endothelial growth factor].
    Hattori Y; Taguchi J; Imai N; Wasano K; Matsuura S; Koharazawa H; Ishigatsubo Y; Fujisawa S
    Rinsho Ketsueki; 2011 Apr; 52(4):219-22. PubMed ID: 21566409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease.
    Mauermann ML
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):153-163. PubMed ID: 29157616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.